Accordingly, recent studies have shown that genetic factors may be linked to cognitive impairments in cancer patients after therapy; for example, the gene encoding apolipoprotein E (APOE), located in chromosome 19, which functions in lipid transport and regulation of inflammation. This evidence concerns the gene APOE and cancer.